Health Care & Life Sciences » Biotechnology | RXi Pharmaceuticals Corp.

RXi Pharmaceuticals Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
14,440.00
8,546.00
10,667.00
12,956.00
3,631.00
Other Current Assets
303.00
442.00
311.00
150.00
201.00
Total Current Assets
14,743.00
8,988.00
10,978.00
13,106.00
3,832.00
Net Property, Plant & Equipment
177.00
183.00
163.00
114.00
248.00
Total Investments and Advances
-
-
-
4.50
-
Long-Term Note Receivable
-
-
-
150.00
-
Other Assets
18.00
18.00
18.00
22.50
18.00
Total Assets
14,938.00
9,189.00
11,159.00
13,397.00
4,098.00
Accounts Payable
163.00
285.00
1,163.00
917.00
511.00
Other Current Liabilities
1,913.00
1,049.00
1,106.00
1,625.00
1,754.00
Total Current Liabilities
2,076.00
1,334.00
2,269.00
2,542.00
2,265.00
Total Liabilities
2,076.00
1,334.00
2,269.00
2,542.00
2,265.00
Common Equity (Total)
2,888.00
1,167.00
8,890.00
7,330.00
1,833.00
Total Shareholders' Equity
12,862.00
7,855.00
8,890.00
10,855.00
1,833.00
Total Equity
12,862.00
7,855.00
8,890.00
10,855.00
1,833.00
Liabilities & Shareholders' Equity
14,938.00
9,189.00
11,159.00
13,397.00
4,098.00
Preferred Stock (Carrying Value)
9,974.00
6,688.00
-
3,525.00
-

About RXi Pharmaceuticals

View Profile
Address
257 Simarano Drive
Marlborough Massachusetts 01752
United States
Employees -
Website http://www.rxipharma.com
Updated 09/14/2018
RXi Pharmaceuticals Corp. is a biotechnology company, which engages in developing therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.